Market Overview:
The global diabetes injection pens market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin delivery devices, and rising awareness about self-management of diabetes. Based on type, the global diabetes injection pens market is segmented into reusable insulin pens and disposable insulin pens. The disposable insulin pen segment is expected to grow at a higher CAGR than the reusable insulin pen segment during the forecast period from 2018 to 2030. This can be attributed to their ease of use and low cost as compared with reusable insulin pens. Based on application, the global diabetes injection pens market is divided into hospital & clinic, retail pharmacy, and online sales segments. The hospital & clinic segment dominates this market owing to increased diagnosis rates for diabetes in hospitals across all regions studied in this research study.
Product Definition:
A diabetes injection pen is a device used to inject insulin. It is important because it makes it easier to accurately administer the medication.
Reusable Insulin Pens:
Reusable insulin pens are devices used to deliver rapid-acting insulin through injection sites. They are portable, easy to use and do not require a blood glucose meter in most cases. The device consists of an insulated reservoir containing the drug, which can be filled with fast or regular acting insulin as per requirement.
Disposable Insulin Pens:
Disposable insulin pens and it's usage in diabetes injection pens market is expected to witness significant growth over the forecast period. The major factor that propels the growth of this industry includes increasing incidences of lifestyle diseases such as diabetes, cancer, and other chronic conditions. Moreover, growing geriatric population base also serves as a high impact rendering driver for disposable insulin pen and it's usage in diabetics injection pens market globally.
Application Insights:
On the basis of application, the market is segmented into hospital and clinic, retail pharmacy, online sales and others. Hospital and clinics held the largest share in 2017 owing to increasing prevalence of diabetes coupled with a rise in demand for insulin injection pens used at hospitals. According to WHO's estimates, by 2040 there will be over 942 million people suffering from diabetes worldwide which is expected to boost product demand over the forecast period.
The online sales segment are anticipated to witness significant growth during the forecast period due largely disposable income levels among most population groups across developing countries such as India & China where majority of products are sold through e-commerce platforms on account of ease in accessibility along with favorable reimbursement policies offered by private insurance companies for purchasing these devices through their healthcare providers directly thereby reducing overall cost associated with medication management thus resulting in increased adoption rate among patients living without health insurance or under public/private coverage schemes. The aforementioned factors are expected fuel market growth during 2018 - 2030 globally.
Regional Analysis:
North America dominated the global diabetes injection pens market in 2017. The presence of a large number of manufacturers coupled with high patient awareness levels and healthcare expenditure levels are some factors attributing to its largest share. In addition, the availability of insurance coverage and an increase in government initiatives that support access to insulin pumps also contribute towards its largest market share.
Asia Pacific is expected to be the fastest-growing region over the forecast period owing to increasing diabetic population along with rising disposable income levels in emerging countries such as China, India, Thailand, Malaysia and Indonesia. Moreover, economic development has led to an improvement in infrastructure facilities for healthcare providers thereby creating a need for better diabetes management solutions including insulin delivery devices such as reusable injectable pen sets.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits. As a result, there is an increased demand for diabetes injection pens, which can help in better management of the disease.
- Technological advancements: Diabetes injection pens are becoming more and more sophisticated with each passing day, thanks to the continuous technological advancements. This has resulted in increased acceptance among users, who find these devices easier and more convenient to use than traditional injections or syringes.
- Growing awareness about diabetes: There is a growing awareness about diabetes across the world, which has led to an increase in the number of people seeking treatment for it. This presents a huge opportunity for players operating in the diabetic injection pens market as they can capitalize on this by offering innovative products that cater to the specific needs of these patients.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Injection Pens Market Research Report
By Type
Reusable Insulin Pens, Disposable Insulin Pens
By Application
Hospital & Clinic, Retail Pharmacy, Online Sales
By Companies
Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Injection Pens Market Report Segments:
The global Diabetes Injection Pens market is segmented on the basis of:
Types
Reusable Insulin Pens, Disposable Insulin Pens
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinic, Retail Pharmacy, Online Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
- Delfu
Highlights of The Diabetes Injection Pens Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Insulin Pens
- Disposable Insulin Pens
- By Application:
- Hospital & Clinic
- Retail Pharmacy
- Online Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Injection Pens Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes injection pens are a type of insulin pen that is used to administer insulin. These pens use a cartridge filled with insulin, which is inserted into the pen's injector. The user then presses the button on the pen to inject the insulin into their body.
Some of the major companies in the diabetes injection pens market are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee, Delfu.
The diabetes injection pens market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Injection Pens Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Injection Pens Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Injection Pens Market - Supply Chain
4.5. Global Diabetes Injection Pens Market Forecast
4.5.1. Diabetes Injection Pens Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Injection Pens Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Injection Pens Market Absolute $ Opportunity
5. Global Diabetes Injection Pens Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Injection Pens Market Size and Volume Forecast by Type
5.3.1. Reusable Insulin Pens
5.3.2. Disposable Insulin Pens
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Injection Pens Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Injection Pens Market Size and Volume Forecast by Application
6.3.1. Hospital & Clinic
6.3.2. Retail Pharmacy
6.3.3. Online Sales
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Injection Pens Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Injection Pens Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Injection Pens Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Injection Pens Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Injection Pens Demand Share Forecast, 2019-2026
9. North America Diabetes Injection Pens Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Injection Pens Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Injection Pens Market Size and Volume Forecast by Application
9.4.1. Hospital & Clinic
9.4.2. Retail Pharmacy
9.4.3. Online Sales
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Injection Pens Market Size and Volume Forecast by Type
9.7.1. Reusable Insulin Pens
9.7.2. Disposable Insulin Pens
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Injection Pens Demand Share Forecast, 2019-2026
10. Latin America Diabetes Injection Pens Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Injection Pens Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Injection Pens Market Size and Volume Forecast by Application
10.4.1. Hospital & Clinic
10.4.2. Retail Pharmacy
10.4.3. Online Sales
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Injection Pens Market Size and Volume Forecast by Type
10.7.1. Reusable Insulin Pens
10.7.2. Disposable Insulin Pens
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Injection Pens Demand Share Forecast, 2019-2026
11. Europe Diabetes Injection Pens Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Injection Pens Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Injection Pens Market Size and Volume Forecast by Application
11.4.1. Hospital & Clinic
11.4.2. Retail Pharmacy
11.4.3. Online Sales
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Injection Pens Market Size and Volume Forecast by Type
11.7.1. Reusable Insulin Pens
11.7.2. Disposable Insulin Pens
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Injection Pens Demand Share, 2019-2026
12. Asia Pacific Diabetes Injection Pens Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Injection Pens Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Injection Pens Market Size and Volume Forecast by Application
12.4.1. Hospital & Clinic
12.4.2. Retail Pharmacy
12.4.3. Online Sales
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Injection Pens Market Size and Volume Forecast by Type
12.7.1. Reusable Insulin Pens
12.7.2. Disposable Insulin Pens
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Injection Pens Demand Share, 2019-2026
13. Middle East & Africa Diabetes Injection Pens Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Injection Pens Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Injection Pens Market Size and Volume Forecast by Application
13.4.1. Hospital & Clinic
13.4.2. Retail Pharmacy
13.4.3. Online Sales
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Injection Pens Market Size and Volume Forecast by Type
13.7.1. Reusable Insulin Pens
13.7.2. Disposable Insulin Pens
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Injection Pens Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Injection Pens Market: Market Share Analysis
14.2. Diabetes Injection Pens Distributors and Customers
14.3. Diabetes Injection Pens Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novo Nordisk
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Eli Lilly
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BD
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ypsomed Holding
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dongbao
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Owen Mumford
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ganlee
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Delfu
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
